Rite Aid Corp (RAD)
$11.75
0.00 (0.00%)
RAD Stock Quote Delayed 15 Minutes
Previous Close
$11.75
Market Cap
12.53B
PE Ratio
-34.56
EPS
-0.34
Volume (Avg. Vol.)
Day's Range
11.75 - 11.75
52-Week Range
0.43 - 23.88
Dividend & Yield
N/A (N/A)
RAD Stock Predictions, Articles, and Rite Aid Corp News
After Last Month’s Epic Rally, Rite Aid Stock Could Go Lower
Outside of another short squeeze, it's tough to see RAD stock going higher long-term. Even after the rally, shares remain a sell.
Investors Will See What They Want in RAD Stock
RAD stock appears like an interesting bet considering its present market discount. However, speculators should be aware that the company’s financial health leaves much to be desired.
To Stay at $20, Rite Aid’s Got to Do More
Although Rite Aid stock has come a long way, the reality is that the fundamental picture is incredibly messy. Management must reveal more substance before investors have any confidence in the beleaguered company.
Rite Aid Stock Is a Bottom Fisher’s Paradise at Its Current Price
Bargains in the health-care sector like RAD stock don't come along all that often. It's time to go against the grain and pick up some shares.
Don’t Be Fooled by the Big Spike of Rite Aid Stock
RAD stock nearly tripled in the last month of 2019, but Rite Aid stock subsequently fell and looks poised for more declines.
Rite Aid Stock Is Still One of the Top Stocks to Avoid in 2020
With a heavy debt load and mounting competition, Rite Aid stock is looking like one to avoid as we begin 2020.
4 Top Stock Trades for Friday: TSLA, RAD, GIS, MED
General Mills, Tesla, Rite Aid and Medifast were our top stock trades from Thursday. Let's look at the charts going into Friday.
Rite Aid Earnings: RAD Stock Rockets 43% Higher on Better-Than-Expected Q3
Rite Aid (RAD) earnings for the U.S. pharmacy company's third quarter of fiscal 2020 have RAD stock flying high on Thursday.
3 Big Stock Charts for Wednesday: Alphabet, AT&T, and Rite Aid
Wednesday's 3 big stock charts highlight recent market winners whose rallies may be petering out.
Even With New CEO, Debt-Laden Rite Aid Stock is Best Avoided for Near Term
RAD stock hasn't benefited when management gave up selling electronic cigarettes while taking on CBD products. That's not the turnaround strategy it needs.
The Comfort Zone Is Holding Rite Aid Stock Back
Believe it or not, Rite Aid has the opportunity to maximize its revenue profile. But getting there is a herculean task, leaving Rite Aid stock an avenue best left for speculators.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
C
